Last Price
0.48 (11.18.09 8:10 PM EST)
Change (%)
- (-)
Volume
-
Open
-
Previous Close
0.48
Day High
0.48
Day Low
0.48
Bid
0.43 x 1000
Ask
0.47 x 500
Average Volume
4,122
Shares Outstanding
24.71M
Market Cap
11.9M
Year High
0.80
Year Low
0.30
Earnings Per Share
N/A
P/E Ratio
N/A
Dividend
N/A
Yield
N/A
Symbol
Last
Change (%)
ANX
0.10
+0.00 (+0.00)
LIXT
0.51
+0.00 (+0.00)
PLMO
0.27
-0.01 (-3.57%)
BLLSF
0.25
+0.00 (+0.00)
FEBTF
0.61
+0.00 (+0.00)
MZEI
0.09
+0.00 (+0.00)
GTHP
1.60
+0.40 (+33.33%)
Tue, Jun 30, 2009
KAI Pharmaceuticals Acquires Patents from Progen, Broadening KAI’s Intellectual Property Estate Covering Peptide-Based Therapies
-
Business Wire
Wed, Apr 22, 2009
Progen Receives Nasdaq Notice Regarding Board Composition
-
PR Newswire
Mon, Apr 20, 2009
Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth
-
PR Newswire
Tue, Mar 10, 2009
Australian Market Report of March 10: No Exciting News to Lift the Market
-
ABN Newswire
Mon, Mar 09, 2009
Avexa’s Proposed Merger With Progen Terminated
-
Business Wire
More Press Releases
Wed, Jul 23, 2008
Unusual 11 Mid-Day Movers 7/23: PHLY, FED, COBR, RDN Higher; PGLA, PFBC, AEHR, ANAD Lower
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3841853 for the full story.
-
StreetInsider
Wed, May 14, 2008
Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047
Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047
-
FOXBusiness.com
Mon, Sep 24, 2007
Progen Pharmaceuticals Phase 2 trial fails
Shares of Progen Pharmaceuticals Ltd. (
Nasdaq: PGLA ) are sliding ahead of the bell after the biotechnology company announced that its Phase 2 trial administering 250mg of PI-88 in combination with the chemotherapeutic agent docetaxel to patients with advanced non small-cell lung cancer failed.
-
SmallCapInvestor.com
StreetInsider.com Pre-Open Movers 09/24
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=2973164 for the full story.
-
StreetInsider
Wed, May 23, 2007
Thomas Weisel Starts Progen Pharmaceuticals (PGLA) at Overweight
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=2338108 for the full story.
-
StreetInsider
More News
Thu, Aug 16, 2007
Micros Report 1 and 2 August 15, 2007 (video)
Micros Report
August 15, 2007
Mike Willingham and Rick Wright host Micros Report every morning on MN1.com
Mike and Rick talked about the some movers from yesterday, and some that were sent in to us by our listeners, including: SMXT (Simex Tech), CNWI (Cardiac Networks), HPLF (Hepalife Tech), PGLA (Progen Pharma.)
Watch part 1 click here
In the second segment, we discussed some potential stock movers, including: GRUS (Grem USA), TLTK (Teletek inc.), and OYSM (Oasys Mobile)
Watch part 2 click here
Leave Comment
Related Entries:
Micros Report 1 and 2 August 14, 2007 (video)
Micros Report 1 - August 15, 2007
Micros Report 2 - August 15, 2007
Micros Report 1 and 2 August 13, 2007 (video)
Micros Report 1 - August 13, 2007
Micros Report 2 - August 13, 2007
Micros Report 1 and 2 August 10, 2007 (video)
Micros Report 1 - August 10, 2007
Micros Report 2 - August 10, 2007
Micros Report 1 and 2 August 9, 2007 (video)
-
MN1
More Podcasts